Ernexa Therapeutics
$0.2
350
-$0.01-4.75% Thursday 20:00
Statistics
Day High
0.21
Day Low
0.2
52W High
4.05
52W Low
0.18
Volume
194,821
Avg. Volume
1,717,027
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
20MayExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-31,888.24%Profit Margin
Unprofitable68,000Revenue
-21.68MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ERNA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
ARK Innovation
ARKK
Mkt Cap0
Invesco QQQ Trust Series 1
QQQ
Mkt Cap0
Vanguard Information Technology
VGT
Mkt Cap0
iShares Expanded Tech-Software Sector
IGV
Mkt Cap0
First Trust Dow Jones Internet Index Fund
FDN
Mkt Cap0
ARK Next Generation Internet
ARKW
Mkt Cap0
State Street SPDR FactSet Innovative Technology
XITK
Mkt Cap0
ROBO Global Robotics and Automation Index
ROBO
Mkt Cap0
First Trust Cloud Computing
SKYY
Mkt Cap0
About
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Show more...
CEO
Mr. Sanjeev Luther
Employees
6
Country
US
ISIN
US1140823089
Listings
0 Comments
Share your thoughts
FAQ
What is Ernexa Therapeutics stock price today?▼
The current price of ERNA is $0.2 USD — it has decreased by -4.75% in the past 24 hours. Watch Ernexa Therapeutics stock price performance more closely on the chart.
What is Ernexa Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Ernexa Therapeutics stocks are traded under the ticker ERNA.
Is Ernexa Therapeutics stock price growing?▼
ERNA stock has risen by +6.08% compared to the previous week, the month change is a -29.65% fall, over the last year Ernexa Therapeutics has showed a +6.03% increase.
When is the next Ernexa Therapeutics earnings date?▼
Ernexa Therapeutics is going to release the next earnings report on May 20, 2026.
What were Ernexa Therapeutics earnings last quarter?▼
ERNA earnings for the last quarter are -0.18 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ernexa Therapeutics revenue for the last year?▼
Ernexa Therapeutics revenue for the last year amounts to 68,000 USD.
What is Ernexa Therapeutics net income for the last year?▼
ERNA net income for the last year is -21.68M USD.
How many employees does Ernexa Therapeutics have?▼
As of April 06, 2026, the company has 6 employees.
In which sector is Ernexa Therapeutics located?▼
Ernexa Therapeutics operates in the Health Care sector.
When did Ernexa Therapeutics complete a stock split?▼
The last stock split for Ernexa Therapeutics was on June 12, 2025 with a ratio of 1:15.
Where is Ernexa Therapeutics headquartered?▼
Ernexa Therapeutics is headquartered in Cambridge, US.